First Header Logo Second Header Logo

Connection

Karen Haas to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications Karen Haas has written about Xenograft Model Antitumor Assays.
Karen Haas
Connection Strength
0.173
Xenograft Model Antitumor Assays
  1. Dyevoich AM, Haas KM. Type I IFN, Ly6C+ cells, and Phagocytes Support Suppression of Peritoneal Carcinomatosis Elicited by a TLR and CLR Agonist Combination. Mol Cancer Ther. 2020 06; 19(6):1232-1242.
    View in: PubMed
    Score: 0.173
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.